LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 48

Search options

  1. Book: Financial crimes

    Dion, Michel / Weisstub, David / Richet, Jean-Loup

    psychological, technological, and ethical issues

    (International library of ethics, law, and the new medicine ; 68)

    2016  

    Series title International library of ethics, law, and the new medicine ; 68
    Collection
    Keywords celebrated cases on financial crimes ; corruption and bribery ; criminal justice ; criminology ; ethical issues of financial crimes ; facets of financial crime ; financial crimes ; law and psychology ; money laundering ; philosophy and crime ; psychological aspects of financial crimes ; psychology of financial crime ; technological issues of financial crimes ; white-collar crime and ethics ; white-collar criminals
    Language English
    Size XIX, 376 S. : Ill., graph. Darst., 23.5 cm x 15.5 cm, 0 g
    Publisher Springer
    Publishing place Cham
    Publishing country Switzerland
    Document type Book
    HBZ-ID HT019015344
    ISBN 978-3-319-32418-0 ; 3-319-32418-7 ; 9783319324197 ; 3319324195
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  2. Book: Financial crimes and existential philosophy

    Dion, Michel

    (Ethical economy: studies in economic ethics and philosophy)

    2016  

    Author's details Michel Dion
    Series title Ethical economy: studies in economic ethics and philosophy
    Keywords Wirtschaftskriminalität ; Wirtschaftsethik ; Philosophie
    Language Undetermined
    Size xxi, 204 Seiten
    Edition Softcover reprint of the hardcover 1st edition 2014
    Publisher Springer
    Publishing place Dordrecht
    Document type Book
    ISBN 9789400773264 ; 9789401779890 ; 9400773269 ; 9401779899
    Database ECONomics Information System

    More links

    Kategorien

  3. Article ; Online: Pantoprazole promotes sustained intestinal carriage of multidrug-resistant Escherichia coli in amoxicillin-treated mice.

    Moaligou, Camille / Dion, Michel / Ishnaiwer, Murad / Dailly, Éric / Batard, Éric / Javaudin, François

    Journal of applied microbiology

    2023  Volume 134, Issue 10

    Abstract: Aims: The main objective of this study was to compare extended-spectrum β-lactamase (ESBL) Escherichia coli fecal titers during 12 days between two groups: mice who received proton pump inhibitors (PPIs) and those that did not.: Methods and results: ... ...

    Abstract Aims: The main objective of this study was to compare extended-spectrum β-lactamase (ESBL) Escherichia coli fecal titers during 12 days between two groups: mice who received proton pump inhibitors (PPIs) and those that did not.
    Methods and results: We tested three different in vivo models: model 1, high inoculum (106 CFU ml-1); model 2, low inoculum (102 CFU ml-1); and model 3, low inoculum and 2-day amoxicillin wash-out. There was no significant difference between the two groups in fecal ESBL E. coli titers in models 1 and 2. The fecal titers of ESBL E. coli were probably too high to show differences in colonization related to PPI treatment. By introducing a 2-day wash-out period after stopping amoxicillin (model 3), the fecal ESBL E. coli titers were higher in the PPI-treated mice during 12 days (3 log versus 11 log day CFU g-1; P < 0.05). This result highlighted that PPIs promote stable ESBL E. coli digestive carriage in mice. Fecal quantitative PCR showed that mice with low ESBL E. coli fecal titers had a much higher concentration of equol-producing bacteria, Muribaculum sp., and Adlercreutzia caecimuris.
    Conclusions: Pantoprazole treatment promotes sustained digestive carriage of ESBL E. coli in amoxicillin-treated mice.
    Language English
    Publishing date 2023-09-27
    Publishing country England
    Document type Journal Article
    ZDB-ID 1358023-1
    ISSN 1365-2672 ; 1364-5072
    ISSN (online) 1365-2672
    ISSN 1364-5072
    DOI 10.1093/jambio/lxad223
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Efficacy of an inulin-based treatment on intestinal colonization by multidrug-resistant E. coli: insight into the mechanism of action.

    Ishnaiwer, Murad / Le Bastard, Quentin / Naour, Maxime / Zeman, Michal / Dailly, Eric / Montassier, Emmanuel / Batard, Eric / Dion, Michel

    Gut microbes

    2024  Volume 16, Issue 1, Page(s) 2347021

    Abstract: Inulin, an increasingly studied dietary fiber, alters intestinal microbiota. The aim of this study was to assess whether inulin decreases intestinal colonization by multidrug ... ...

    Abstract Inulin, an increasingly studied dietary fiber, alters intestinal microbiota. The aim of this study was to assess whether inulin decreases intestinal colonization by multidrug resistant
    MeSH term(s) Animals ; Inulin/pharmacology ; Inulin/metabolism ; Mice ; Gastrointestinal Microbiome/drug effects ; Escherichia coli/drug effects ; Escherichia coli/genetics ; Feces/microbiology ; Amoxicillin/pharmacology ; Pantoprazole/pharmacology ; Drug Resistance, Multiple, Bacterial ; beta-Lactamases/metabolism ; beta-Lactamases/genetics ; Dysbiosis/microbiology ; Dysbiosis/drug therapy ; Anti-Bacterial Agents/pharmacology ; Escherichia coli Infections/drug therapy ; Escherichia coli Infections/microbiology ; Female ; Prebiotics/administration & dosage
    Chemical Substances Inulin (9005-80-5) ; Amoxicillin (804826J2HU) ; Pantoprazole (D8TST4O562) ; beta-Lactamases (EC 3.5.2.6) ; Anti-Bacterial Agents ; Prebiotics
    Language English
    Publishing date 2024-04-29
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2575755-6
    ISSN 1949-0984 ; 1949-0984
    ISSN (online) 1949-0984
    ISSN 1949-0984
    DOI 10.1080/19490976.2024.2347021
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Epistemological and pedagogical challenges of teaching international business ethics courses

    Dion, Michel

    Journal of teaching in international business Vol. 26, No. 2 , p. 109-135

    2015  Volume 26, Issue 2, Page(s) 109–135

    Author's details Michel Dion
    Keywords Business ethics courses ; Ethical theories ; Literature ; Religious/spiritual traditions
    Language English
    Publisher Taylor & Francis
    Publishing place Philadelphia, Pa.
    Document type Article
    ZDB-ID 1075237-7
    ISSN 0897-5930
    Database ECONomics Information System

    More links

    Kategorien

  6. Article: In vitro and in vivo activity of new strains of Bacillus subtilis against ESBL‐producing Escherichia coli: an experimental study

    Ishnaiwer, Murad / Bezabih, YihieneΙw / Javaudin, François / Sassi, Mohamed / Bemer, Pascale / Batard, Eric / Dion, Michel

    Journal of applied microbiology. 2022 Mar., v. 132, no. 3

    2022  

    Abstract: AIMS: The gastro‐intestinal tract is a major reservoir of extended‐spectrum beta‐lactamase (ESBL) producing Escherichia coli. Bacillus spores may be used as probiotics to decrease digestive colonization by ESBL‐E. coli. Our aim was to assess the in vitro ...

    Abstract AIMS: The gastro‐intestinal tract is a major reservoir of extended‐spectrum beta‐lactamase (ESBL) producing Escherichia coli. Bacillus spores may be used as probiotics to decrease digestive colonization by ESBL‐E. coli. Our aim was to assess the in vitro and in vivo activity of new Bacillus strains against ESBL‐E. coli. METHODS AND RESULTS: We screened the in vitro activity of 50 Bacillus strains against clinical isolates of ESBL‐E. coli and selected B. subtilis strains CH311 and S3B. Both strains decreased ESBL‐E. coli titers by 4 log₁₀ CFU L⁻¹ in an in vitro model of gut content, whereas the B. subtilis CU1 strain did not. In a murine model of intestinal colonization by ESBL‐E. coli, CH311 and S3B did not decrease fecal titers of ESBL‐E. coli. Ten sequences of putative antimicrobial peptides were identified in the genomes of CH311 and S3B, but not in CU1. CONCLUSIONS: Two new B. subtilis strains showed strong in vitro activity against ESBL‐E. coli. SIGNIFICANCE AND IMPACT OF STUDY: Despite strong in vitro activities of new B. subtilis strains against ESBL‐E. coli, intestinal colonisation was not altered by curative Bacillus treatment even if their spores proved to germinate in the gut. Thus, this work underlines the importance of in vivo experiments to identify efficient probiotics. The use of potential antimicrobial compounds identified by genome sequencing remains an attractive alternative to explore.
    Keywords Bacillus subtilis ; Escherichia coli ; animal models ; antimicrobial peptides ; beta-lactamase ; beta-lactamase bacteria ; digestive tract ; genome ; intestines ; probiotics
    Language English
    Dates of publication 2022-03
    Size p. 2270-2279.
    Publishing place John Wiley & Sons, Ltd
    Document type Article
    Note JOURNAL ARTICLE
    ZDB-ID 1358023-1
    ISSN 1365-2672 ; 1364-5072
    ISSN (online) 1365-2672
    ISSN 1364-5072
    DOI 10.1111/jam.15329
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  7. Article ; Online: ABO Blood Types and COVID-19: Spurious, Anecdotal, or Truly Important Relationships? A Reasoned Review of Available Data.

    Pendu, Jacques Le / Breiman, Adrien / Rocher, Jézabel / Dion, Michel / Ruvoën-Clouet, Nathalie

    Viruses

    2021  Volume 13, Issue 2

    Abstract: Since the emergence of COVID-19, many publications have reported associations with ABO blood types. Despite between-study discrepancies, an overall consensus has emerged whereby blood group O appears associated with a lower risk of COVID-19, while non-O ... ...

    Abstract Since the emergence of COVID-19, many publications have reported associations with ABO blood types. Despite between-study discrepancies, an overall consensus has emerged whereby blood group O appears associated with a lower risk of COVID-19, while non-O blood types appear detrimental. Two major hypotheses may explain these findings: First, natural anti-A and anti-B antibodies could be partially protective against SARS-CoV-2 virions carrying blood group antigens originating from non-O individuals. Second, O individuals are less prone to thrombosis and vascular dysfunction than non-O individuals and therefore could be at a lesser risk in case of severe lung dysfunction. Here, we review the literature on the topic in light of these hypotheses. We find that between-study variation may be explained by differences in study settings and that both mechanisms are likely at play. Moreover, as frequencies of ABO phenotypes are highly variable between populations or geographical areas, the ABO coefficient of variation, rather than the frequency of each individual phenotype is expected to determine impact of the ABO system on virus transmission. Accordingly, the ABO coefficient of variation correlates with COVID-19 prevalence. Overall, despite modest apparent risk differences between ABO subtypes, the ABO blood group system might play a major role in the COVID-19 pandemic when considered at the population level.
    MeSH term(s) ABO Blood-Group System/blood ; COVID-19/blood ; COVID-19/epidemiology ; COVID-19/microbiology ; Disease Susceptibility/blood ; Disease Susceptibility/epidemiology ; Disease Susceptibility/microbiology ; Disease Susceptibility/pathology ; Humans ; Incidence ; Isoantibodies/blood ; Microbiota ; Odds Ratio ; SARS-CoV-2 ; Thrombosis/blood ; Thrombosis/epidemiology ; Thrombosis/microbiology
    Chemical Substances ABO Blood-Group System ; Isoantibodies
    Language English
    Publishing date 2021-01-22
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2516098-9
    ISSN 1999-4915 ; 1999-4915
    ISSN (online) 1999-4915
    ISSN 1999-4915
    DOI 10.3390/v13020160
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Characterization and engineering of two new GH9 and GH48 cellulases from a Bacillus pumilus isolated from Lake Bogoria

    Ogonda, Lydia A / Saumonneau, Amélie / Dion, Michel / Muge, Edward K / Wamalwa, Benson M / Mulaa, Francis J / Tellier, Charles

    Biotechnology letters. 2021 Mar., v. 43, no. 3

    2021  

    Abstract: OBJECTIVES: To search for new alkaliphilic cellulases and to improve their efficiency on crystalline cellulose through molecular engineering RESULTS: Two novel cellulases, BpGH9 and BpGH48, from a Bacillus pumilus strain were identified, cloned and ... ...

    Abstract OBJECTIVES: To search for new alkaliphilic cellulases and to improve their efficiency on crystalline cellulose through molecular engineering RESULTS: Two novel cellulases, BpGH9 and BpGH48, from a Bacillus pumilus strain were identified, cloned and biochemically characterized. BpGH9 is a modular endocellulase belonging to the glycoside hydrolase 9 family (GH9), which contains a catalytic module (GH) and a carbohydrate-binding module belonging to class 3 and subclass c (CBM3c). This enzyme is extremely tolerant to high alkali pH and remains significantly active at pH 10. BpGH48 is an exocellulase, belonging to the glycoside hydrolase 48 family (GH48) and acts on the reducing end of oligo-β1,4 glucanes. A truncated form of BpGH9 and a chimeric fusion with an additional CBM3a module was constructed. The deletion of the CBM3c module results in a significant decline in the catalytic activity. However, fusion of CBM3a, although in a non native position, enhanced the activity of BpGH9 on crystalline cellulose. CONCLUSIONS: A new alkaliphilic endocellulase BpGH9, was cloned and engineered as a fusion protein (CBM3a-BpGH9), which led to an improved activity on crystalline cellulose.
    Keywords Bacillus pumilus ; biotechnology ; carbohydrate binding ; catalytic activity ; cellulases ; cellulose ; glycosides ; lakes ; pH
    Language English
    Dates of publication 2021-03
    Size p. 691-700.
    Publishing place Springer Netherlands
    Document type Article
    Note NAL-AP-2-clean
    ZDB-ID 423853-9
    ISSN 1573-6776 ; 0141-5492
    ISSN (online) 1573-6776
    ISSN 0141-5492
    DOI 10.1007/s10529-020-03056-z
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  9. Article: Christian mutual funds, codes of ethics and corporate illegalities

    Dion, Michel

    International journal of social economics Vol. 36, No. 9/10 , p. 916-929

    2009  Volume 36, Issue 9, Page(s) 916–929

    Author's details Michel Dion
    Keywords Investmentfonds ; Christentum ; Unternehmensethik ; Nachhaltige Kapitalanlage ; Corporate Governance
    Language English
    Publisher Emerald
    Publishing place Bradford
    Document type Article
    ZDB-ID 188656-3
    Database ECONomics Information System

    More links

    Kategorien

  10. Article ; Online: In vitro and in vivo activity of new strains of Bacillus subtilis against ESBL-producing Escherichia coli: an experimental study.

    Ishnaiwer, Murad / Bezabih, YihieneΙw / Javaudin, François / Sassi, Mohamed / Bemer, Pascale / Batard, Eric / Dion, Michel

    Journal of applied microbiology

    2021  Volume 132, Issue 3, Page(s) 2270–2279

    Abstract: Aims: The gastro-intestinal tract is a major reservoir of extended-spectrum beta-lactamase (ESBL) producing Escherichia coli. Bacillus spores may be used as probiotics to decrease digestive colonization by ESBL-E. coli. Our aim was to assess the in ... ...

    Abstract Aims: The gastro-intestinal tract is a major reservoir of extended-spectrum beta-lactamase (ESBL) producing Escherichia coli. Bacillus spores may be used as probiotics to decrease digestive colonization by ESBL-E. coli. Our aim was to assess the in vitro and in vivo activity of new Bacillus strains against ESBL-E. coli.
    Methods and results: We screened the in vitro activity of 50 Bacillus strains against clinical isolates of ESBL-E. coli and selected B. subtilis strains CH311 and S3B. Both strains decreased ESBL-E. coli titers by 4 log
    Conclusions: Two new B. subtilis strains showed strong in vitro activity against ESBL-E. coli.
    Significance and impact of study: Despite strong in vitro activities of new B. subtilis strains against ESBL-E. coli, intestinal colonisation was not altered by curative Bacillus treatment even if their spores proved to germinate in the gut. Thus, this work underlines the importance of in vivo experiments to identify efficient probiotics. The use of potential antimicrobial compounds identified by genome sequencing remains an attractive alternative to explore.
    MeSH term(s) Animals ; Anti-Bacterial Agents/therapeutic use ; Bacillus subtilis ; Escherichia coli/genetics ; Escherichia coli Infections/drug therapy ; Mice ; Microbial Sensitivity Tests ; beta-Lactamases/genetics
    Chemical Substances Anti-Bacterial Agents ; beta-Lactamases (EC 3.5.2.6)
    Language English
    Publishing date 2021-10-24
    Publishing country England
    Document type Journal Article
    ZDB-ID 1358023-1
    ISSN 1365-2672 ; 1364-5072
    ISSN (online) 1365-2672
    ISSN 1364-5072
    DOI 10.1111/jam.15329
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top